Nasus Pharma Ltd (NYSE:NSRX) has filed to raise $11 million in an IPO of its ordinary shares, according to SEC F-1 registration information. The company is developing an intranasal powder spray for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback